Vaccitech plc - ADR

The momentum for this stock is not very good. Vaccitech plc - ADR is not a good value stock. Vaccitech plc - ADR is not very popular among insiders. Tradey thinks it is not wise to invest in Vaccitech plc - ADR.

News

Barinthus stock falls 18%, day after changing name from Vaccitech

SeekingAlpha.com: All News Barinthus Biotherapeutics (BRNS) stock fell 18% Tuesday, the day after it changed its name from Vaccitech and said it planned to present data on its hepatitis B drug at AASLD.\n more…

Vaccitech rebrands as Barinthus, plans to present data at AASLD meeting

SeekingAlpha.com: All News Vaccitech (VACC) said that it has rebranded at Barinthus Therapeutics (BRNS) to reflect its expansion beyond developing vaccines. Read more here.\n more…

Vaccitech renames as Barinthus Biotherapeutics, announces presentations

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and Cancer

Globe Newswire New Corporate Brand to be Unveiled at AASLD Liver Meeting 2023 with Interim Data OXFORD, United Kingdom, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), formerly...\n more…

Vaccitech plc (NASDAQ:VACC) Short Interest Down 71.4% in October

Zolmax Vaccitech plc (NASDAQ:VACC Get Free Report) saw a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 159,200 shares, a drop...\n more…

Vaccitech plc (NASDAQ:VACC) Sees Significant Increase in Short Interest

Zolmax Vaccitech plc (NASDAQ:VACC Get Free Report) saw a significant growth in short interest during the month of September. As of September 30th, there was short interest totalling 555,800 shares...\n more…